Robert C. Green

In this insightful discussion, Robert C. Green, a geneticist and physician at Harvard Medical School, reveals the groundbreaking BabySeq Project that sequences newborn DNA to uncover hidden health risks. He emphasizes the shift from treating illness to predicting it, showcasing how early genetic screening can empower families and enhance pediatric care. Green shares compelling cases where early detection led to proactive health interventions, and he explores how technology and genomics could revolutionize healthcare for future generations.

Dr. Robert C. Green, a genomics researcher and co-founder of Nurture Genomics, discusses the groundbreaking BabySeq project that sequences infants' DNA to uncover hidden health risks. He highlights the balance between potential life-saving information and ethical dilemmas, such as privacy and the fear of eugenics. Parents share powerful stories of how early detection changed their child's health trajectory, while bioethicist Dr. Lainie Friedman Ross raises concerns about overdiagnosis and public trust in genomic testing. The conversation dives deep into the future of preventive genomics.

Dr. Robert C. Green, a pioneering medical geneticist, discusses the revolutionary BabySeq Project, the first to sequence the DNA of healthy infants. He reveals that 4% to 12% of newborns carry actionable mutations, which can lead to early interventions. Green shares heartwarming family stories demonstrating the impact of early diagnosis and emphasizes the importance of making genomic testing accessible to all parents. He also tackles privacy concerns and advocates for ongoing genomic reanalysis, envisioning a future where genetics and AI transform preventive healthcare.